V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160787 | 20062029 | 1.51 | 55.8 | Neo-adjuvant (N) | null | 2019-07-09 | ECX | N | N | ECX | 101123479 |
| 20160792 | 20062030 | 1.7 | 54.4 | Neo-adjuvant (N) | 2019-12-31 | 2020-01-14 | ECX | N | N | ECX | 100372547 |
| 20160793 | 20062031 | 1.72 | 78 | Neo-adjuvant (N) | 2018-01-06 | 2018-01-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101149266 |
| 20160794 | 20062032 | 1.58 | 73.6 | Neo-adjuvant (N) | 2017-05-06 | 2017-05-06 | ECX | N | N | ECX | 101130084 |
| 20160796 | 20062033 | 1.7 | 60 | Adjuvant (A) | 2020-01-23 | 2020-01-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100318883 |
| 20160797 | 20062034 | 1.68 | 75.8 | Palliative (P) | 2017-02-08 | 2017-02-22 | ECX | N | N | ECX | 101450227 |
| 20160798 | 20062035 | 1.75 | 45 | Curative (C) | 2018-06-26 | 2018-07-03 | ECX | 2 | N | ECX | 100329079 |
| 20160799 | 20062036 | 1.6 | 76.5 | Adjuvant (A) | 2020-03-01 | 2020-03-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100824600 |
| 20160800 | 20062037 | 1.65 | 57.5 | Adjuvant (A) | 2019-01-26 | 2019-01-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101788487 |
| 20160801 | 20062038 | 1.58 | 78.5 | Palliative (P) | 2018-09-02 | 2018-09-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100676632 |
| 20160804 | 20062039 | 1.58 | 53.6 | Palliative (P) | 2017-02-03 | 2017-02-03 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100359554 |
| 20160805 | 20062040 | 1.82 | 66.35 | Neo-adjuvant (N) | null | 2018-06-11 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100341961 |
| 20160808 | 20062041 | 1.59 | 49 | null | 2020-09-08 | 2020-09-17 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101066368 |
| 20160809 | 20062042 | 1.63 | 65.8 | Adjuvant (A) | 2016-04-12 | 2016-05-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100389304 |
| 20160811 | 20062043 | 1.62 | 52 | Palliative (P) | 2016-03-15 | 2016-03-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100202985 |
| 20160812 | 20062044 | 1.77 | 81 | Curative (C) | 2017-04-08 | 2017-04-08 | ECX | 2 | N | ECX | 101296758 |
| 20160813 | 20062045 | 1.72 | 81.9 | Palliative (P) | 2019-05-13 | 2019-05-23 | ECX | N | N | ECX | 101583267 |
| 20160815 | 20062046 | 1.68 | 71.7 | Palliative (P) | 2019-11-19 | 2019-12-06 | ECX | N | N | ECX | 101842671 |
| 20160816 | 20062047 | 1.74 | 91.8 | Neo-adjuvant (N) | 2017-07-12 | 2017-08-03 | ECX | 02 | null | ECX | 101808799 |
| 20160818 | 20062048 | 1.79 | 56.5 | Neo-adjuvant (N) | 2016-04-01 | 2016-04-03 | ECX | 02 | N | ECX | 101177710 |
| 20160819 | 20062049 | 1.71 | 75.5 | Palliative (P) | 2019-07-20 | 2019-07-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100480355 |
| 20160820 | 20062050 | 1.79 | 73 | Palliative (P) | 2018-04-28 | 2018-05-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101604196 |
| 20160822 | 20062051 | 1.55 | 98 | Adjuvant (A) | 2020-03-16 | 2020-03-30 | ECX | N | N | ECX | 101060211 |
| 20160824 | 20062052 | 1.8 | 78.4 | null | 2019-08-04 | 2019-08-11 | ECX | N | N | ECX | 100626367 |
| 20160825 | 20062053 | 1.73 | 91 | Neo-adjuvant (N) | 2017-03-10 | 2017-03-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100377373 |
| 20160827 | 20062054 | 1.52 | 52 | Neo-adjuvant (N) | 2019-12-23 | 2020-01-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100825362 |
| 20160828 | 20062055 | 1.7 | 78 | Adjuvant (A) | 2017-12-03 | 2017-12-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100009861 |
| 20160832 | 20062056 | null | 71 | Palliative (P) | 2017-03-03 | 2017-03-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100851855 |
| 20160833 | 20062057 | 1.73 | 76.6 | Neo-adjuvant (N) | 2017-01-30 | 2017-03-12 | ECX | 02 | N | ECX | 100778074 |
| 20160836 | 20062058 | 1.86 | 75.9 | Adjuvant (A) | 2020-02-20 | 2020-02-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101194775 |
| 20160838 | 20062059 | 1.61 | 49.6 | Palliative (P) | 2018-03-19 | 2018-03-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101585533 |
| 20160839 | 20062060 | 1.76 | 73 | Palliative (P) | 2017-05-01 | 2017-05-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100535636 |
| 20160840 | 20062061 | 1.6 | 78.2 | Neo-adjuvant (N) | 2019-05-19 | 2019-05-19 | ECX | 02 | N | ECX | 100948870 |
| 20160842 | 20062062 | 1.76 | 61.2 | Palliative (P) | 2016-04-30 | 2016-05-28 | ECX | 02 | N | ECX | 101414088 |
| 20160844 | 20062063 | 1.66 | 88.2 | null | null | 2018-03-03 | ECX | 02 | N | ECX | 101454048 |
| 20160845 | 20062064 | 1.7 | 76.8 | Palliative (P) | 2018-08-13 | 2018-09-07 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101098238 |
| 20160846 | 20062065 | 1.67 | 54 | Curative (C) | 2019-02-25 | 2019-03-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101610017 |
| 20160849 | 20062066 | 1.57 | 103.6 | Adjuvant (A) | 2017-09-10 | 2017-09-24 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100469116 |
| 20160850 | 20062067 | 1.47 | 71 | Palliative (P) | 2017-07-01 | 2017-07-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101539198 |
| 20160852 | 20062068 | 1.81 | 89.5 | Adjuvant (A) | 2019-10-30 | 2019-11-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101838873 |
| 20160854 | 20062069 | 1.7 | 75.6 | Neo-adjuvant (N) | 2018-04-19 | 2018-04-25 | ECX | 2 | N | ECX | 101478761 |
| 20160855 | 20062070 | 1.76 | 84 | Palliative (P) | 2016-07-24 | 2016-08-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101541371 |
| 20160856 | 20062071 | 1.93 | 54 | Neo-adjuvant (N) | 2016-06-08 | 2016-06-08 | ECX | 02 | N | ECX | 101676290 |
| 20160858 | 20062072 | 1.73 | 79.4 | Neo-adjuvant (N) | 2020-01-02 | 2020-01-09 | ECX | null | N | ECX | 100478662 |
| 20160863 | 20062073 | 1.68 | 70.9 | Adjuvant (A) | 2019-07-14 | 2019-07-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100543626 |
| 20160865 | 20062074 | 1.68 | null | Curative (C) | 2016-09-16 | 2016-09-19 | ECX | N | N | ECX | 100306689 |
| 20160866 | 20062075 | 1.54 | 64.7 | Neo-adjuvant (N) | 2019-07-14 | 2019-08-04 | ECX | N | N | ECX | 100326327 |
| 20160867 | 20062076 | 1.69 | 49.4 | Neo-adjuvant (N) | 2018-10-28 | 2018-11-03 | ECX | 2 | N | ECX | 100588140 |
| 20160869 | 20062077 | 1.8 | 98.9 | Adjuvant (A) | 2019-02-15 | 2019-02-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100060270 |
| 20160871 | 20062078 | 1.7 | 66 | Curative (C) | 2017-07-22 | 2017-07-28 | ECX | N | null | ECX | 101583803 |